| Symbol |
Name |
Standardized Value |
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
2.29774
|
|
RBM15
|
RNA binding motif protein 15
|
2.17179
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
1.64397
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
1.55912
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
1.38341
|
|
JAK3
|
Janus kinase 3
|
1.3027
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
1.18453
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
1.14009
|
|
GLIS2
|
GLIS family zinc finger 2
|
1.13163
|
|
ACIN1
|
apoptotic chromatin condensation inducer 1
|
1.07908
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
1.07362
|
|
THPO
|
thrombopoietin
|
1.06438
|
|
IL3
|
interleukin 3
|
1.05597
|
|
PF4
|
platelet factor 4
|
1.05177
|
|
RUNX1
|
runt-related transcription factor 1
|
1.01047
|
|
RBM6
|
RNA binding motif protein 6
|
0.97002
|
|
JAK2
|
Janus kinase 2
|
0.957033
|
|
ZFPM1
|
zinc finger protein, FOG family member 1
|
0.949519
|
|
CD33
|
CD33 molecule
|
0.935799
|
|
MPO
|
myeloperoxidase
|
0.919673
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
0.908142
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
0.89623
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
0.889258
|
|
OPRK1
|
opioid receptor, kappa 1
|
0.889258
|
|
DUSP14
|
dual specificity phosphatase 14
|
0.869187
|
|
ST7L
|
suppression of tumorigenicity 7 like
|
0.848716
|
|
SETD1B
|
SET domain containing 1B
|
0.848716
|
|
CD34
|
CD34 molecule
|
0.833558
|
|
CD7
|
CD7 molecule
|
0.827819
|
|
TUBB1
|
tubulin, beta 1 class VI
|
0.808949
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
0.796642
|
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
|
0.787213
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
0.775341
|
|
SMC3
|
structural maintenance of chromosomes 3
|
0.765943
|
|
QRSL1
|
glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1
|
0.763086
|
|
NUP98
|
nucleoporin 98kDa
|
0.729357
|
|
MAP3K9
|
mitogen-activated protein kinase kinase kinase 9
|
0.722482
|
|
ETV6
|
ets variant 6
|
0.70233
|
|
MKL2
|
MKL/myocardin-like 2
|
0.701124
|
|
F8
|
coagulation factor VIII, procoagulant component
|
0.662387
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
0.641827
|
|
JAK1
|
Janus kinase 1
|
0.636708
|
|
ST18
|
suppression of tumorigenicity 18, zinc finger
|
0.626888
|
|
TYK2
|
tyrosine kinase 2
|
0.626888
|
|
HEXIM1
|
hexamethylene bis-acetamide inducible 1
|
0.613965
|
|
CDA
|
cytidine deaminase
|
0.608885
|
|
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae)
|
0.59952
|
|
MYL9
|
myosin, light chain 9, regulatory
|
0.585497
|
|
GP9
|
glycoprotein IX (platelet)
|
0.582384
|
|
SCARB2
|
scavenger receptor class B, member 2
|
0.581217
|
|
WRB
|
tryptophan rich basic protein
|
0.569941
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
0.540055
|
|
VWF
|
von Willebrand factor
|
0.534635
|
|
ACPP
|
acid phosphatase, prostate
|
0.524588
|
|
PACRG
|
PARK2 co-regulated
|
0.524202
|
|
EPOR
|
erythropoietin receptor
|
0.523045
|
|
SCARB1
|
scavenger receptor class B, member 1
|
0.523045
|
|
AGO2
|
argonaute RISC catalytic component 2
|
0.521502
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
0.516494
|
|
CBS
|
cystathionine-beta-synthase
|
0.513033
|
|
MEIS1
|
Meis homeobox 1
|
0.513033
|
|
NFYA
|
nuclear transcription factor Y, alpha
|
0.504207
|
|
TRAF5
|
TNF receptor-associated factor 5
|
0.494266
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
0.493122
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
0.485505
|
|
CCNT1
|
cyclin T1
|
0.479807
|
|
FLT3
|
fms-related tyrosine kinase 3
|
0.479047
|
|
ECT2
|
epithelial cell transforming 2
|
0.477151
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
0.47374
|
|
STAG2
|
stromal antigen 2
|
0.460883
|
|
GYPE
|
glycophorin E (MNS blood group)
|
0.454847
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
0.452962
|
|
TRIB1
|
tribbles pseudokinase 1
|
0.450324
|
|
GATA2
|
GATA binding protein 2
|
0.450324
|
|
TRAF2
|
TNF receptor-associated factor 2
|
0.442418
|
|
AURKA
|
aurora kinase A
|
0.440162
|
|
LAT
|
linker for activation of T cells
|
0.43941
|
|
PDS5B
|
PDS5 cohesin associated factor B
|
0.433772
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
0.424765
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
0.420266
|
|
TUBB
|
tubulin, beta class I
|
0.410909
|
|
ZYX
|
zyxin
|
0.40008
|
|
WNT2B
|
wingless-type MMTV integration site family, member 2B
|
0.395235
|
|
SPN
|
sialophorin
|
0.394863
|
|
CD14
|
CD14 molecule
|
0.394491
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
0.386308
|
|
IL11
|
interleukin 11
|
0.381481
|
|
CSF2RA
|
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
|
0.376661
|
|
PNMA1
|
paraneoplastic Ma antigen 1
|
0.370737
|
|
RAD21
|
RAD21 homolog (S. pombe)
|
0.363716
|
|
EVPL
|
envoplakin
|
0.359289
|
|
SEMA6C
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C
|
0.356341
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
0.350452
|
|
FANCL
|
Fanconi anemia, complementation group L
|
0.347511
|
|
NOTCH1
|
notch 1
|
0.344574
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
0.341639
|
|
CLNK
|
cytokine-dependent hematopoietic cell linker
|
0.340906
|
|
CD9
|
CD9 molecule
|
0.331756
|
|
VCL
|
vinculin
|
0.324823
|
|
BST2
|
bone marrow stromal cell antigen 2
|
0.315729
|
|
MX2
|
MX dynamin-like GTPase 2
|
0.305948
|
|
LONP1
|
lon peptidase 1, mitochondrial
|
0.300894
|
|
NFKBIB
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
|
0.296931
|
|
KITLG
|
KIT ligand
|
0.294053
|
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase
|
0.287952
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
0.280796
|
|
HBG2
|
hemoglobin, gamma G
|
0.270464
|
|
IL9
|
interleukin 9
|
0.266558
|
|
MYOCD
|
myocardin
|
0.266558
|
|
APOC1
|
apolipoprotein C-I
|
0.26514
|
|
NUMB
|
numb homolog (Drosophila)
|
0.25983
|
|
ADGRV1
|
adhesion G protein-coupled receptor V1
|
0.255594
|
|
SH2B3
|
SH2B adaptor protein 3
|
0.248203
|
|
RHOB
|
ras homolog family member B
|
0.243645
|
|
SETD2
|
SET domain containing 2
|
0.242245
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
0.238403
|
|
TGFB1
|
transforming growth factor, beta 1
|
0.232836
|
|
WNT2
|
wingless-type MMTV integration site family member 2
|
0.231102
|
|
BCR
|
breakpoint cluster region
|
0.229024
|
|
TFRC
|
transferrin receptor
|
0.226262
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
0.22454
|
|
HOXA10
|
homeobox A10
|
0.223509
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
0.222822
|
|
CD19
|
CD19 molecule
|
0.222479
|
|
CDK9
|
cyclin-dependent kinase 9
|
0.21974
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
0.216332
|
|
ALAS2
|
5'-aminolevulinate synthase 2
|
0.215992
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
0.211261
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
0.209248
|
|
CD38
|
CD38 molecule
|
0.197742
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
0.1936
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
0.190476
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
0.180367
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
0.178403
|
|
CD22
|
CD22 molecule
|
0.177301
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
0.174354
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
0.170789
|
|
CHL1
|
cell adhesion molecule L1-like
|
0.163111
|
